{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:06:11Z","timestamp":1793505971988,"version":"4.5.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,7,2]],"date-time":"2012-07-02T00:00:00Z","timestamp":1341187200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/2.0"},{"start":{"date-parts":[[2012,7,2]],"date-time":"2012-07-02T00:00:00Z","timestamp":1341187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Alzheimer\u2019s disease (AD) is the most prevalent form of age-related dementia, and its effect on society increases exponentially as the population ages. Accumulating evidence suggests that neuroinflammation, mediated by the brain\u2019s innate immune system, contributes to AD neuropathology and exacerbates the course of the disease. However, there is no experimental evidence for a causal link between systemic inflammation or neuroinflammation and the onset of the disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The viral mimic, polyriboinosinic-polyribocytidilic acid (PolyI:C) was used to stimulate the immune system of experimental animals. Wild-type (WT) and transgenic mice were exposed to this cytokine inducer prenatally (gestation day (GD)17) and\/or in adulthood. Behavioral, immunological, immunohistochemical, and biochemical analyses of AD-associated neuropathologic changes were performed during aging.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We found that a systemic immune challenge during late gestation predisposes WT mice to develop AD-like neuropathology during the course of aging. They display chronic elevation of inflammatory cytokines, an increase in the levels of hippocampal amyloid precursor protein (APP) and its proteolytic fragments, altered Tau phosphorylation, and mis-sorting to somatodendritic compartments, and significant impairments in working memory in old age. If this prenatal infection is followed by a second immune challenge in adulthood, the phenotype is strongly exacerbated, and mimics AD-like neuropathologic changes. These include deposition of APP and its proteolytic fragments, along with Tau aggregation, microglia activation and reactive gliosis. Whereas A\u03b2 peptides were not significantly enriched in extracellular deposits of double immune-challenged WT mice at 15 months, they dramatically increased in age-matched immune-challenged transgenic AD mice, precisely around the inflammation-induced accumulations of APP and its proteolytic fragments, in striking similarity to the post-mortem findings in human patients with AD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Chronic inflammatory conditions induce age-associated development of an AD-like phenotype in WT mice, including the induction of APP accumulations, which represent a seed for deposition of aggregation-prone peptides. The PolyI:C mouse model therefore provides a unique tool to investigate the molecular mechanisms underlying the earliest pathophysiological changes preceding fibrillary A\u03b2 plaque deposition and neurofibrillary tangle formations in a physiological context of aging. Based on the similarity between the changes in immune-challenged mice and the development of AD in humans, we suggest that systemic infections represent a major risk factor for the development of AD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/1742-2094-9-151","type":"journal-article","created":{"date-parts":[[2012,7,2]],"date-time":"2012-07-02T04:14:08Z","timestamp":1341202448000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":357,"title":["Systemic immune challenges trigger and drive Alzheimer-like neuropathology in mice"],"prefix":"10.1186","volume":"9","author":[{"given":"Dimitrije","family":"Krstic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrita","family":"Madhusudan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Doehner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prisca","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Notter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudine","family":"Imhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Manalastas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Hilfiker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Pfister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Schwerdel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Riether","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urs","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Knuesel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,7,2]]},"reference":[{"key":"699_CR1_699","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1080\/13550280290100969","volume":"8","author":"PL McGeer","year":"2002","unstructured":"McGeer PL, McGeer EG: Local neuroinflammation and the progression of Alzheimer\u2019s disease. J Neurovirol 2002, 8:529\u2013538.","journal-title":"J Neurovirol"},{"key":"699_CR2_699","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1097\/00005072-199655100-00008","volume":"55","author":"LF Lue","year":"1996","unstructured":"Lue LF, Brachova L, Civin WH, Rogers J: Inflammation, Abeta deposition, and neurofibrillary tangle formation as correlates of Alzheimer's disease neurodegeneration. J Neuropathol Exp Neurol 1996, 55:1083\u20131088.","journal-title":"J Neuropathol Exp Neurol"},{"key":"699_CR3_699","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.nbd.2008.08.001","volume":"32","author":"P Edison","year":"2008","unstructured":"Edison P, Archer HA, Gerhard A, Hinz R, Pavese N, Turkheimer FE, Hammers A, Tai YF, Fox N, Kennedy A, Rossor M, Brooks DJ: Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study. Neurobiol Dis 2008, 32:412\u2013419.","journal-title":"Neurobiol Dis"},{"key":"699_CR4_699","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/ng.439","volume":"41","author":"JC Lambert","year":"2009","unstructured":"Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, Combarros O, Zelenika D, Bullido MJ, Tavernier B, Letenneur L, Bettens K, Berr C, Pasquier F, Fi\u00e9vet N, Barberger-Gateau P, Engelborghs S, De Deyn P, Mateo I, Franck A, Helisalmi S, Porcellini E, Hanon O, Investigators European Alzheimer's Disease Initiative, de Pancorbo MM, Lendon C, Dufouil C, Jaillard C, Leveillard T, Alvarez V, Bosco P, Mancuso M, Panza F, Nacmias B, Boss\u00f9 P, Piccardi P, Annoni G, Seripa D, Galimberti D, Hannequin D, Licastro F, Soininen H, Ritchie K, Blanch\u00e9 H, Dartigues JF, Tzourio C, Gut I, Van Broeckhoven C, Alp\u00e9rovitch A, Lathrop M, Amouyel P: Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer\u2019s disease. Nat Genet 2009, 41:1094\u20131099.","journal-title":"Nat Genet"},{"key":"699_CR5_699","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/ana.10265","volume":"52","author":"R Schmidt","year":"2002","unstructured":"Schmidt R, Schmidt H, Curb JD, Masaki K, White LR, Launer LJ: Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study. Ann Neurol 2002, 52:168\u2013174.","journal-title":"Ann Neurol"},{"key":"699_CR6_699","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1001\/archneur.61.5.668","volume":"61","author":"MJ Engelhart","year":"2004","unstructured":"Engelhart MJ, Geerlings MI, Meijer J, Kiliaan A, Ruitenberg A, van Swieten JC, Stijnen T, Hofman A, Witteman JC, Breteler MM: Inflammatory proteins in plasma and the risk of dementia: the Rotterdam study. Arch Neurol 2004, 61:668\u2013672.","journal-title":"Arch Neurol"},{"key":"699_CR7_699","first-page":"1005","volume":"12","author":"T Wyss-Coray","year":"2006","unstructured":"Wyss-Coray T: Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat Med 2006, 12:1005\u20131015.","journal-title":"Nat Med"},{"key":"699_CR8_699","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/glia.10153","volume":"40","author":"J Rogers","year":"2002","unstructured":"Rogers J, Strohmeyer R, Kovelowski CJ, Li R: Microglia and inflammatory mechanisms in the clearance of amyloid beta peptide. Glia 2002, 40:260\u2013269.","journal-title":"Glia"},{"key":"699_CR9_699","doi-asserted-by":"publisher","first-page":"7611","DOI":"10.1073\/pnas.86.19.7611","volume":"86","author":"WS Griffin","year":"1989","unstructured":"Griffin WS, Stanley LC, Ling C, White L, MacLeod V, Perrot LJ, White CL 3rd, Araoz C: Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci USA 1989, 86:7611\u20137615.","journal-title":"Proc Natl Acad Sci USA"},{"key":"699_CR10_699","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/0197-4580(96)00104-2","volume":"17","author":"JG Sheng","year":"1996","unstructured":"Sheng JG, Ito K, Skinner RD, Mrak RE, Rovnaghi CR, Van Eldik LJ, Griffin WS: In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis. Neurobiol Aging 1996, 17:761\u2013766.","journal-title":"Neurobiol Aging"},{"key":"699_CR11_699","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.neurobiolaging.2004.05.010","volume":"26","author":"RE Mrak","year":"2005","unstructured":"Mrak RE, Griffin WS: Glia and their cytokines in progression of neurodegeneration. Neurobiol Aging 2005, 26:349\u2013354.","journal-title":"Neurobiol Aging"},{"key":"699_CR12_699","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1212\/WNL.47.2.425","volume":"47","author":"PL McGeer","year":"1996","unstructured":"McGeer PL, Schulzer M, McGeer EG: Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology 1996, 47:425\u2013432.","journal-title":"Neurology"},{"key":"699_CR13_699","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1001\/jama.289.21.2819","volume":"289","author":"PS Aisen","year":"2003","unstructured":"Aisen PS, Schafer KA, Grundman M, Pfeiffer E, Sano M, Davis KL, Farlow MR, Jin S, Thomas RG, Thal LJ, Alzheimer's Disease Cooperative Study: Effects of rofecoxib or naproxen versus placebo on Alzheimer disease progression: a randomized controlled trial. JAMA 2003, 289:2819\u20132826.","journal-title":"JAMA"},{"key":"699_CR14_699","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000096588","volume":"23","author":"H Soininen","year":"2007","unstructured":"Soininen H, West C, Robbins J, Niculescu L: Long-term efficacy and safety of celecoxib in Alzheimer's disease. Dement Geriatr Cogn Disord 2007, 23:8\u201321.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"699_CR15_699","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1038\/sj.npp.1300690","volume":"30","author":"LJ Thal","year":"2005","unstructured":"Thal LJ, Ferris SH, Kirby L, Block GA, Lines CR, Yuen E, Assaid C, Nessly ML, Norman BA, Baranak CC, Reines SA, Rofecoxib Protocol 078 study group: A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment. Neuropsychopharmacology 2005, 30:1204\u20131215.","journal-title":"Neuropsychopharmacology"},{"key":"699_CR16_699","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.jalz.2010.12.014","volume":"7","author":"JC Breitner","year":"2011","unstructured":"Breitner JC, Baker LD, Montine TJ, Meinert CL, Lyketsos CG, Ashe KH, Brandt J, Craft S, Evans DE, Green RC, Ismail MS, Martin BK, Mullan MJ, Sabbagh M, Tariot PN, ADAPT Research Group: Extended results of the Alzheimer's disease anti-inflammatory prevention trial. Alzheimers Dement 2011, 7:402\u2013411.","journal-title":"Alzheimers Dement"},{"key":"699_CR17_699","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/35099560","volume":"413","author":"L Alexopoulou","year":"2001","unstructured":"Alexopoulou L, Holt AC, Medzhitov R, Flavell RA: Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001, 413:732\u2013738.","journal-title":"Nature"},{"key":"699_CR18_699","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.bbi.2006.12.007","volume":"21","author":"C Cunningham","year":"2007","unstructured":"Cunningham C, Campion S, Teeling J, Felton L, Perry VH: The sickness behaviour and CNS inflammatory mediator profile induced by systemic challenge of mice with synthetic double-stranded RNA (PolyI:C). Brain Behav Immun 2007, 21:490\u2013502.","journal-title":"Brain Behav Immun"},{"key":"699_CR19_699","doi-asserted-by":"publisher","first-page":"4752","DOI":"10.1523\/JNEUROSCI.0099-06.2006","volume":"26","author":"U Meyer","year":"2006","unstructured":"Meyer U, Nyffeler M, Engler A, Urwyler A, Schedlowski M, Knuesel I, Yee BK, Feldon J: The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J Neurosci 2006, 26:4752\u20134762.","journal-title":"J Neurosci"},{"key":"699_CR20_699","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.bbi.2007.09.012","volume":"22","author":"U Meyer","year":"2008","unstructured":"Meyer U, Nyffeler M, Yee BK, Knuesel I, Feldon J: Adult brain and behavioral pathological markers of prenatal immune challenge during early\/middle and late fetal development in mice. Brain Behav Immun 2008, 22:469\u2013486.","journal-title":"Brain Behav Immun"},{"key":"699_CR21_699","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.neurobiolaging.2007.08.011","volume":"30","author":"I Knuesel","year":"2009","unstructured":"Knuesel I, Nyffeler M, Morm\u00e8de C, Muhia M, Meyer U, Pietropaolo S, Yee BK, Pryce CR, LaFerla FM, Marighetto A, Feldon J: Age-related accumulation of Reelin in amyloid-like deposits. Neurobiol Aging 2009, 30:697\u2013716.","journal-title":"Neurobiol Aging"},{"key":"699_CR22_699","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.pneurobio.2010.04.002","volume":"91","author":"I Knuesel","year":"2010","unstructured":"Knuesel I: Reelin-mediated signaling in neuropsychiatric and neurodegenerative diseases. Prog Neurobiol 2010, 91:257\u2013274.","journal-title":"Prog Neurobiol"},{"key":"699_CR23_699","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","volume":"39","author":"S Oddo","year":"2003","unstructured":"Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM: Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 2003, 39:409\u2013421.","journal-title":"Neuron"},{"key":"699_CR24_699","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0166-4328(01)00451-X","volume":"133","author":"RM Deacon","year":"2002","unstructured":"Deacon RM, Bannerman DM, Kirby BP, Croucher A, Rawlins JN: Effects of cytotoxic hippocampal lesions in mice on a cognitive test battery. Behav Brain Res 2002, 133:57\u201368.","journal-title":"Behav Brain Res"},{"key":"699_CR25_699","volume-title":"The mouse brain in stereotaxic coordinates","author":"G Paxinos","year":"2001","unstructured":"Paxinos G, Franklin K: The mouse brain in stereotaxic coordinates. 2nd edition. San Diego: Academic; 2001.","edition":"2"},{"key":"699_CR26_699","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.3233\/JAD-2010-1333","volume":"19","author":"J Doehner","year":"2010","unstructured":"Doehner J, Madhusudan A, Konietzko U, Fritschy JM, Knuesel I: Co-localization of Reelin and proteolytic AbetaPP fragments in hippocampal plaques in aged wild-type mice. J Alzheimers Dis 2010, 19:1339\u20131357.","journal-title":"J Alzheimers Dis"},{"key":"699_CR27_699","doi-asserted-by":"publisher","first-page":"9228","DOI":"10.1523\/JNEUROSCI.0418-10.2010","volume":"30","author":"S Kocherhans","year":"2010","unstructured":"Kocherhans S, Madhusudan A, Doehner J, Breu KS, Nitsch RM, Fritschy JM, Knuesel I: Reduced Reelin expression accelerates amyloid-beta plaque formation and tau pathology in transgenic Alzheimer's disease mice. J Neurosci 2010, 30:9228\u20139240.","journal-title":"J Neurosci"},{"key":"699_CR28_699","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1046\/j.1460-9568.2002.01980.x","volume":"15","author":"I Knuesel","year":"2002","unstructured":"Knuesel I, Riban V, Zuellig RA, Schaub MC, Grady RM, Sanes JR, Fritschy JM: Increased vulnerability to kainate-induced seizures in utrophin-knockout mice. Eur J Neurosci 2002, 15:1474\u20131484.","journal-title":"Eur J Neurosci"},{"key":"699_CR29_699","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1177\/002215549904700601","volume":"47","author":"SA Schnell","year":"1999","unstructured":"Schnell SA, Staines WA, Wessendorf MW: Reduction of lipofuscin-like autofluorescence in fluorescently labeled tissue. J Histochem Cytochem 1999, 47:719\u2013730.","journal-title":"J Histochem Cytochem"},{"key":"699_CR30_699","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/978-1-60761-744-0_7","volume":"670","author":"SW Pimplikar","year":"2011","unstructured":"Pimplikar SW, Suryanarayana A: Detection of APP intracellular domain in brain tissue. Methods Mol Biol 2011, 670:85\u201391.","journal-title":"Methods Mol Biol"},{"key":"699_CR31_699","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s00213-008-1166-z","volume":"199","author":"H Anisman","year":"2008","unstructured":"Anisman H, Gibb J, Hayley S: Influence of continuous infusion of interleukin1-beta on depression-related processes in mice: corticosterone, circulating cytokines, brain monoamines, and cytokine mRNA expression. Psychopharmacology 2008, 199:199\u2013244.","journal-title":"Psychopharmacology"},{"key":"699_CR32_699","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1038\/nn1997","volume":"10","author":"UK Hanisch","year":"2007","unstructured":"Hanisch UK, Kettenmann H: Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 2007, 10:1387\u20131394.","journal-title":"Nat Neurosci"},{"key":"699_CR33_699","doi-asserted-by":"publisher","first-page":"e11866","DOI":"10.1371\/journal.pone.0011866","volume":"5","author":"K Ghosal","year":"2010","unstructured":"Ghosal K, Stathopoulos A, Pimplikar SW: APP intracellular domain impairs adult neurogenesis in transgenic mice by inducing neuroinflammation. PLoS One 2010, 5:e11866.","journal-title":"PLoS One"},{"key":"699_CR34_699","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.neuron.2010.11.030","volume":"68","author":"BR Hoover","year":"2010","unstructured":"Hoover BR, Reed MN, Su J, Penrod RD, Kotilinek LA, Grant MK, Pitstick R, Carlson GA, Lanier LM, Yuan LL, Ashe KH, Liao D: Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron 2010, 68:1067\u20131081.","journal-title":"Neuron"},{"key":"699_CR35_699","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/nrneurol.2010.17","volume":"6","author":"VH Perry","year":"2010","unstructured":"Perry VH, Nicoll JA, Holmes C: Microglia in neurodegenerative disease. Nat Rev Neurol 2010, 6:193\u2013201.","journal-title":"Nat Rev Neurol"},{"key":"699_CR36_699","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.brainresbull.2009.07.012","volume":"80","author":"D Rossi","year":"2009","unstructured":"Rossi D, Volterra A: Astrocytic dysfunction: insights on the role in neurodegeneration. Brain Res Bull 2009, 80:224\u2013232.","journal-title":"Brain Res Bull"},{"key":"699_CR37_699","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.mrfmmm.2009.08.016","volume":"690","author":"S Fuller","year":"2010","unstructured":"Fuller S, Steele M, M\u00fcnch G: Activated astroglia during chronic inflammation in Alzheimer's disease\u2013do they neglect their neurosupportive roles? Mutat Res 2010, 690:40\u201349.","journal-title":"Mutat Res"},{"key":"699_CR38_699","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E: Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991, 82:239\u2013259.","journal-title":"Acta Neuropathol"},{"key":"699_CR39_699","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3233\/JAD-2002-4311","volume":"4","author":"P Grammas","year":"2002","unstructured":"Grammas P, Yamada M, Zlokovic B: The cerebromicrovasculature: a key player in the pathogenesis of Alzheimer\u2019s disease. J Alzheimers Dis 2002, 4:217\u2013223.","journal-title":"J Alzheimers Dis"},{"key":"699_CR40_699","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/alzrt6","volume":"1","author":"RO Weller","year":"2009","unstructured":"Weller RO, Preston SD, Subash M, Carare RO: Cerebral amyloid angiopathy in the aetiology and immunotherapy of Alzheimer disease. Alzheimers Res Ther 2009, 1:6.","journal-title":"Alzheimers Res Ther"},{"key":"699_CR41_699","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1159\/000095638","volume":"3","author":"L Arnaud","year":"2006","unstructured":"Arnaud L, Robakis NK, Figueiredo-Pereira ME: It may take inflammation, phosphorylation and ubiquitination to \u2018tangle\u2019 in Alzheimer\u2019s disease. Neurodegener Dis 2006, 3:313\u2013319.","journal-title":"Neurodegener Dis"},{"key":"699_CR42_699","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1212\/WNL.0b013e318225ae07","volume":"77","author":"C Holmes","year":"2011","unstructured":"Holmes C, Cunningham C, Zotova E, Culliford D, Perry VH: Proinflammatory cytokines, sickness behavior, and Alzheimer disease. Neurology 2011, 77:212\u2013218.","journal-title":"Neurology"},{"key":"699_CR43_699","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1006\/dbio.2001.0393","volume":"238","author":"P Herbomel","year":"2001","unstructured":"Herbomel P, Thisse B, Thisse C: Zebrafish early macrophages colonize cephalic mesenchyme and developing brain, retina, and epidermis through a M-CSF receptor-dependent invasive process. Dev Biol 2001, 238:274\u2013288.","journal-title":"Dev Biol"},{"key":"699_CR44_699","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1194637","volume":"330","author":"F Ginhoux","year":"2010","unstructured":"Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, Gokhan S, Mehler MF, Conway SJ, Ng LG, Stanley ER, Samokhvalov IM, Merad M: Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 2010, 330:841\u2013845.","journal-title":"Science"},{"key":"699_CR45_699","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1749-6632.2000.tb06195.x","volume":"99","author":"CA Colton","year":"2000","unstructured":"Colton CA, Chernyshev ON, Gilbert DL, Vitek MP: Microglial contribution to oxidative stress in Alzheimer's disease. Ann N Y Acad Sci 2000, 99:292\u2013307.","journal-title":"Ann N Y Acad Sci"},{"key":"699_CR46_699","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/glia.10301","volume":"45","author":"BE Flanary","year":"2004","unstructured":"Flanary BE, Streit WJ: Progressive telomere shortening occurs in cultured rat microglia, but not astrocytes. Glia 2004, 45:75\u201388.","journal-title":"Glia"},{"key":"699_CR47_699","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1038\/emboj.2011.152","volume":"30","author":"HJ Yun","year":"2011","unstructured":"Yun HJ, Yoon JH, Lee JK, Noh KT, Yoon KW, Oh SP, Oh HJ, Chae JS, Hwang SG, Kim EH, Maul GG, Lim DS, Choi EJ: Daxx mediates activation-induced cell death in microglia by triggering MST1 signalling. EMBO J 2011, 30:2465\u20132476.","journal-title":"EMBO J"},{"key":"699_CR48_699","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00401-009-0556-6","volume":"118","author":"WJ Streit","year":"2009","unstructured":"Streit WJ, Braak H, Xue QS, Bechmann I: Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer\u2019s disease. Acta Neuropathol 2009, 118:475\u2013485.","journal-title":"Acta Neuropathol"},{"key":"699_CR49_699","doi-asserted-by":"publisher","first-page":"10075","DOI":"10.1073\/pnas.89.21.10075","volume":"89","author":"JD Buxbaum","year":"1992","unstructured":"Buxbaum JD, Oishi M, Chen HI, Pinkas-Kramarski R, Jaffe EA, Gandy SE, Greengard P: Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta\/A4 amyloid protein precursor. Proc Natl Acad Sci USA 1992, 89:10075\u201310078.","journal-title":"Proc Natl Acad Sci USA"},{"key":"699_CR50_699","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/1742-2094-8-175","volume":"8","author":"L Liu","year":"2011","unstructured":"Liu L, Aboud O, Jones RA, Mrak RE, Griffin ST, Barger SW: Apolipoprotein E expression is elevated by interleukin 1 and other interleukin 1-induced factors. J Neuroinflammation 2011, 8:175.","journal-title":"J Neuroinflammation"},{"key":"699_CR51_699","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1523\/JNEUROSCI.23-05-01605.2003","volume":"23","author":"Y Li","year":"2003","unstructured":"Li Y, Liu L, Barger SW, Griffin WS: Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway. J Neurosci 2003, 23:1605\u20131611.","journal-title":"J Neurosci"},{"key":"699_CR52_699","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/mp.2009.82","volume":"14","author":"DK Lahiri","year":"2009","unstructured":"Lahiri DK, Maloney B, Zawia NH: The LEARn model: an epigenetic explanation for idiopathic neurobiological diseases. Mol Psychiatry 2009, 14:992\u20131003.","journal-title":"Mol Psychiatry"},{"key":"699_CR53_699","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1042\/BST0390886","volume":"39","author":"H Johnston","year":"2011","unstructured":"Johnston H, Boutin H, Allan SM: Assessing the contribution of inflammation in models of Alzheimer's disease. Biochem Soc Trans 2011, 39:886\u2013890.","journal-title":"Biochem Soc Trans"},{"key":"699_CR54_699","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jnr.20093","volume":"77","author":"WJ Streit","year":"2004","unstructured":"Streit WJ: Microglia and Alzheimer's disease pathogenesis. J Neurosci Res 2004, 77:1\u20138.","journal-title":"J Neurosci Res"},{"key":"699_CR55_699","doi-asserted-by":"publisher","first-page":"22707","DOI":"10.1074\/jbc.M611050200","volume":"282","author":"JL Jankowsky","year":"2007","unstructured":"Jankowsky JL, Younkin LH, Gonzales V, Fadale DJ, Slunt HH, Lester HA, Younkin SG, Borchelt DR: Rodent A beta modulates the solubility and distribution of amyloid deposits in transgenic mice. J Biol Chem 2007, 282:22707\u201322720.","journal-title":"J Biol Chem"},{"key":"699_CR56_699","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/1742-2094-8-112","volume":"8","author":"S Kyrkanides","year":"2011","unstructured":"Kyrkanides S, Tallents RH, Miller JH, Olschowka ME, Johnson R, Yang M, Olschowka JA, Brouxhon SM, O\u2019Banion MK: Osteoarthritis accelerates and exacerbates Alzheimer\u2019s disease pathology in mice. J Neuroinflammation 2011, 8:112.","journal-title":"J Neuroinflammation"},{"key":"699_CR57_699","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.nbd.2006.05.010","volume":"23","author":"T van Groen","year":"2006","unstructured":"van Groen T, Kiliaan AJ, Kadish I: Deposition of mouse amyloid beta in human APP\/PS1 double and single AD model transgenic mice. Neurobiol Dis 2006, 23:653\u2013662.","journal-title":"Neurobiol Dis"},{"key":"699_CR58_699","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3233\/JAD-2008-14406","volume":"14","author":"KR Brunden","year":"2008","unstructured":"Brunden KR, Trojanowski JQ, Lee VM: Evidence that non-fibrillar tau causes pathology linked to neurodegeneration and behavioral impairments. J Alzheimers Dis 2008, 14:393\u2013399.","journal-title":"J Alzheimers Dis"},{"key":"699_CR59_699","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/0896-6273(91)90052-2","volume":"6","author":"DJ Selkoe","year":"1991","unstructured":"Selkoe DJ: The molecular pathology of Alzheimer's disease. Neuron 1991, 6:487\u2013498.","journal-title":"Neuron"},{"key":"699_CR60_699","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA: Alzheimer's disease: the amyloid cascade hypothesis. Science 1992, 256:184\u2013185.","journal-title":"Science"},{"key":"699_CR61_699","doi-asserted-by":"publisher","first-page":"16755","DOI":"10.1523\/JNEUROSCI.4521-10.2010","volume":"30","author":"K Herrup","year":"2010","unstructured":"Herrup K: Reimagining Alzheimer's disease\u2013an age-based hypothesis. J Neurosci 2010, 30:16755\u201316762.","journal-title":"J Neurosci"},{"key":"699_CR62_699","first-page":"428","volume":"21","author":"MG Spillantini","year":"1998","unstructured":"Spillantini MG, Goedert M: Tau protein pathology in neurodegenerative diseases. TINS 1998, 21:428\u2013433.","journal-title":"TINS"},{"key":"699_CR63_699","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.bbrc.2007.04.187","volume":"358","author":"R Porzig","year":"2007","unstructured":"Porzig R, Singer D, Hoffman R: Epitope mapping of mAbs AT8 and Tau5 directed against hyperphosphorylated regions of the human tau protein. Biochem Biophys Res Commun 2007, 358:644\u2013649.","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-2094-9-151.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/1742-2094-9-151\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-2094-9-151","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-2094-9-151.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T05:00:27Z","timestamp":1714107627000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/1742-2094-9-151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,2]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["699"],"URL":"https:\/\/doi.org\/10.1186\/1742-2094-9-151","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717962719.793464684","asserted-by":"object"}]},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,2]]},"assertion":[{"value":"21 February 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"151"}}